Li, Z., Li, Z., Cheng, X., Zhang, H., Yang, C., Xu, Q., . . . Wu, R. Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: A multicenter randomized clinical trial. Elsevier.
Chicago Style (17th ed.) CitationLi, Zhengping, et al. Intermediate-dose Immune Tolerance Induction Outperforms with Faster Success, Less Bleeding, and No Added Cost in Comparison with Low Dose: A Multicenter Randomized Clinical Trial. Elsevier.
MLA (9th ed.) CitationLi, Zhengping, et al. Intermediate-dose Immune Tolerance Induction Outperforms with Faster Success, Less Bleeding, and No Added Cost in Comparison with Low Dose: A Multicenter Randomized Clinical Trial. Elsevier.
Warning: These citations may not always be 100% accurate.